Global Oral Contraceptive Market Growth 2022-2028

Global Oral Contraceptive Market Growth 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Contraceptive Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Oral Contraceptive by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Oral Contraceptive by Country/Region, 2017, 2022 & 2028
2.2 Oral Contraceptive Segment by Type
2.2.1 Combination
2.2.2 Progestin Only
2.2.3 Others
2.3 Oral Contraceptive Sales by Type
2.3.1 Global Oral Contraceptive Sales Market Share by Type (2017-2022)
2.3.2 Global Oral Contraceptive Revenue and Market Share by Type (2017-2022)
2.3.3 Global Oral Contraceptive Sale Price by Type (2017-2022)
2.4 Oral Contraceptive Segment by Application
2.4.1 Male
2.4.2 Female
2.5 Oral Contraceptive Sales by Application
2.5.1 Global Oral Contraceptive Sale Market Share by Application (2017-2022)
2.5.2 Global Oral Contraceptive Revenue and Market Share by Application (2017-2022)
2.5.3 Global Oral Contraceptive Sale Price by Application (2017-2022)
3 Global Oral Contraceptive by Company
3.1 Global Oral Contraceptive Breakdown Data by Company
3.1.1 Global Oral Contraceptive Annual Sales by Company (2020-2022)
3.1.2 Global Oral Contraceptive Sales Market Share by Company (2020-2022)
3.2 Global Oral Contraceptive Annual Revenue by Company (2020-2022)
3.2.1 Global Oral Contraceptive Revenue by Company (2020-2022)
3.2.2 Global Oral Contraceptive Revenue Market Share by Company (2020-2022)
3.3 Global Oral Contraceptive Sale Price by Company
3.4 Key Manufacturers Oral Contraceptive Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Contraceptive Product Location Distribution
3.4.2 Players Oral Contraceptive Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Oral Contraceptive by Geographic Region
4.1 World Historic Oral Contraceptive Market Size by Geographic Region (2017-2022)
4.1.1 Global Oral Contraceptive Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Oral Contraceptive Annual Revenue by Geographic Region
4.2 World Historic Oral Contraceptive Market Size by Country/Region (2017-2022)
4.2.1 Global Oral Contraceptive Annual Sales by Country/Region (2017-2022)
4.2.2 Global Oral Contraceptive Annual Revenue by Country/Region
4.3 Americas Oral Contraceptive Sales Growth
4.4 APAC Oral Contraceptive Sales Growth
4.5 Europe Oral Contraceptive Sales Growth
4.6 Middle East & Africa Oral Contraceptive Sales Growth
5 Americas
5.1 Americas Oral Contraceptive Sales by Country
5.1.1 Americas Oral Contraceptive Sales by Country (2017-2022)
5.1.2 Americas Oral Contraceptive Revenue by Country (2017-2022)
5.2 Americas Oral Contraceptive Sales by Type
5.3 Americas Oral Contraceptive Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Contraceptive Sales by Region
6.1.1 APAC Oral Contraceptive Sales by Region (2017-2022)
6.1.2 APAC Oral Contraceptive Revenue by Region (2017-2022)
6.2 APAC Oral Contraceptive Sales by Type
6.3 APAC Oral Contraceptive Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oral Contraceptive by Country
7.1.1 Europe Oral Contraceptive Sales by Country (2017-2022)
7.1.2 Europe Oral Contraceptive Revenue by Country (2017-2022)
7.2 Europe Oral Contraceptive Sales by Type
7.3 Europe Oral Contraceptive Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oral Contraceptive by Country
8.1.1 Middle East & Africa Oral Contraceptive Sales by Country (2017-2022)
8.1.2 Middle East & Africa Oral Contraceptive Revenue by Country (2017-2022)
8.2 Middle East & Africa Oral Contraceptive Sales by Type
8.3 Middle East & Africa Oral Contraceptive Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Contraceptive
10.3 Manufacturing Process Analysis of Oral Contraceptive
10.4 Industry Chain Structure of Oral Contraceptive
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Contraceptive Distributors
11.3 Oral Contraceptive Customer
12 World Forecast Review for Oral Contraceptive by Geographic Region
12.1 Global Oral Contraceptive Market Size Forecast by Region
12.1.1 Global Oral Contraceptive Forecast by Region (2023-2028)
12.1.2 Global Oral Contraceptive Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral Contraceptive Forecast by Type
12.7 Global Oral Contraceptive Forecast by Application
13 Key Players Analysis
13.1 Pfizer, Inc.
13.1.1 Pfizer, Inc. Company Information
13.1.2 Pfizer, Inc. Oral Contraceptive Product Offered
13.1.3 Pfizer, Inc. Oral Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer, Inc. Main Business Overview
13.1.5 Pfizer, Inc. Latest Developments
13.2 Bayer AG
13.2.1 Bayer AG Company Information
13.2.2 Bayer AG Oral Contraceptive Product Offered
13.2.3 Bayer AG Oral Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bayer AG Main Business Overview
13.2.5 Bayer AG Latest Developments
13.3 Merck & Co., Inc.
13.3.1 Merck & Co., Inc. Company Information
13.3.2 Merck & Co., Inc. Oral Contraceptive Product Offered
13.3.3 Merck & Co., Inc. Oral Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Merck & Co., Inc. Main Business Overview
13.3.5 Merck & Co., Inc. Latest Developments
13.4 Janssen Global Services, LLC
13.4.1 Janssen Global Services, LLC Company Information
13.4.2 Janssen Global Services, LLC Oral Contraceptive Product Offered
13.4.3 Janssen Global Services, LLC Oral Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Janssen Global Services, LLC Main Business Overview
13.4.5 Janssen Global Services, LLC Latest Developments
13.5 Mankind Pharma Ltd.
13.5.1 Mankind Pharma Ltd. Company Information
13.5.2 Mankind Pharma Ltd. Oral Contraceptive Product Offered
13.5.3 Mankind Pharma Ltd. Oral Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Mankind Pharma Ltd. Main Business Overview
13.5.5 Mankind Pharma Ltd. Latest Developments
13.6 Teva Pharmaceutical Industries Ltd
13.6.1 Teva Pharmaceutical Industries Ltd Company Information
13.6.2 Teva Pharmaceutical Industries Ltd Oral Contraceptive Product Offered
13.6.3 Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.6.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.7 Allergan, plc (Actavis)
13.7.1 Allergan, plc (Actavis) Company Information
13.7.2 Allergan, plc (Actavis) Oral Contraceptive Product Offered
13.7.3 Allergan, plc (Actavis) Oral Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Allergan, plc (Actavis) Main Business Overview
13.7.5 Allergan, plc (Actavis) Latest Developments
13.8 Piramal Enterprises Ltd.
13.8.1 Piramal Enterprises Ltd. Company Information
13.8.2 Piramal Enterprises Ltd. Oral Contraceptive Product Offered
13.8.3 Piramal Enterprises Ltd. Oral Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Piramal Enterprises Ltd. Main Business Overview
13.8.5 Piramal Enterprises Ltd. Latest Developments
13.9 Beijing Zizhu Pharm
13.9.1 Beijing Zizhu Pharm Company Information
13.9.2 Beijing Zizhu Pharm Oral Contraceptive Product Offered
13.9.3 Beijing Zizhu Pharm Oral Contraceptive Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Beijing Zizhu Pharm Main Business Overview
13.9.5 Beijing Zizhu Pharm Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Oral Contraceptive Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Oral Contraceptive Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Combination
Table 4. Major Players of Progestin Only
Table 5. Major Players of Others
Table 6. Global Oral Contraceptive Sales by Type (2017-2022) & (K Units)
Table 7. Global Oral Contraceptive Sales Market Share by Type (2017-2022)
Table 8. Global Oral Contraceptive Revenue by Type (2017-2022) & ($ million)
Table 9. Global Oral Contraceptive Revenue Market Share by Type (2017-2022)
Table 10. Global Oral Contraceptive Sale Price by Type (2017-2022) & (USD/Unit)
Table 11. Global Oral Contraceptive Sales by Application (2017-2022) & (K Units)
Table 12. Global Oral Contraceptive Sales Market Share by Application (2017-2022)
Table 13. Global Oral Contraceptive Revenue by Application (2017-2022)
Table 14. Global Oral Contraceptive Revenue Market Share by Application (2017-2022)
Table 15. Global Oral Contraceptive Sale Price by Application (2017-2022) & (USD/Unit)
Table 16. Global Oral Contraceptive Sales by Company (2020-2022) & (K Units)
Table 17. Global Oral Contraceptive Sales Market Share by Company (2020-2022)
Table 18. Global Oral Contraceptive Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Oral Contraceptive Revenue Market Share by Company (2020-2022)
Table 20. Global Oral Contraceptive Sale Price by Company (2020-2022) & (USD/Unit)
Table 21. Key Manufacturers Oral Contraceptive Producing Area Distribution and Sales Area
Table 22. Players Oral Contraceptive Products Offered
Table 23. Oral Contraceptive Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Oral Contraceptive Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Oral Contraceptive Sales Market Share Geographic Region (2017-2022)
Table 28. Global Oral Contraceptive Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Oral Contraceptive Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Oral Contraceptive Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Oral Contraceptive Sales Market Share by Country/Region (2017-2022)
Table 32. Global Oral Contraceptive Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Oral Contraceptive Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Oral Contraceptive Sales by Country (2017-2022) & (K Units)
Table 35. Americas Oral Contraceptive Sales Market Share by Country (2017-2022)
Table 36. Americas Oral Contraceptive Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Oral Contraceptive Revenue Market Share by Country (2017-2022)
Table 38. Americas Oral Contraceptive Sales by Type (2017-2022) & (K Units)
Table 39. Americas Oral Contraceptive Sales Market Share by Type (2017-2022)
Table 40. Americas Oral Contraceptive Sales by Application (2017-2022) & (K Units)
Table 41. Americas Oral Contraceptive Sales Market Share by Application (2017-2022)
Table 42. APAC Oral Contraceptive Sales by Region (2017-2022) & (K Units)
Table 43. APAC Oral Contraceptive Sales Market Share by Region (2017-2022)
Table 44. APAC Oral Contraceptive Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Oral Contraceptive Revenue Market Share by Region (2017-2022)
Table 46. APAC Oral Contraceptive Sales by Type (2017-2022) & (K Units)
Table 47. APAC Oral Contraceptive Sales Market Share by Type (2017-2022)
Table 48. APAC Oral Contraceptive Sales by Application (2017-2022) & (K Units)
Table 49. APAC Oral Contraceptive Sales Market Share by Application (2017-2022)
Table 50. Europe Oral Contraceptive Sales by Country (2017-2022) & (K Units)
Table 51. Europe Oral Contraceptive Sales Market Share by Country (2017-2022)
Table 52. Europe Oral Contraceptive Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Oral Contraceptive Revenue Market Share by Country (2017-2022)
Table 54. Europe Oral Contraceptive Sales by Type (2017-2022) & (K Units)
Table 55. Europe Oral Contraceptive Sales Market Share by Type (2017-2022)
Table 56. Europe Oral Contraceptive Sales by Application (2017-2022) & (K Units)
Table 57. Europe Oral Contraceptive Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Oral Contraceptive Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Oral Contraceptive Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Oral Contraceptive Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Oral Contraceptive Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Oral Contraceptive Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Oral Contraceptive Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Oral Contraceptive Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Oral Contraceptive Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Oral Contraceptive
Table 67. Key Market Challenges & Risks of Oral Contraceptive
Table 68. Key Industry Trends of Oral Contraceptive
Table 69. Oral Contraceptive Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Oral Contraceptive Distributors List
Table 72. Oral Contraceptive Customer List
Table 73. Global Oral Contraceptive Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Oral Contraceptive Sales Market Forecast by Region
Table 75. Global Oral Contraceptive Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Oral Contraceptive Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Oral Contraceptive Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Oral Contraceptive Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Oral Contraceptive Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Oral Contraceptive Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Oral Contraceptive Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Oral Contraceptive Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Oral Contraceptive Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Oral Contraceptive Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Oral Contraceptive Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Oral Contraceptive Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Oral Contraceptive Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Oral Contraceptive Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Oral Contraceptive Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Oral Contraceptive Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Oral Contraceptive Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Oral Contraceptive Revenue Market Share Forecast by Application (2023-2028)
Table 93. Pfizer, Inc. Basic Information, Oral Contraceptive Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer, Inc. Oral Contraceptive Product Offered
Table 95. Pfizer, Inc. Oral Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 96. Pfizer, Inc. Main Business
Table 97. Pfizer, Inc. Latest Developments
Table 98. Bayer AG Basic Information, Oral Contraceptive Manufacturing Base, Sales Area and Its Competitors
Table 99. Bayer AG Oral Contraceptive Product Offered
Table 100. Bayer AG Oral Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 101. Bayer AG Main Business
Table 102. Bayer AG Latest Developments
Table 103. Merck & Co., Inc. Basic Information, Oral Contraceptive Manufacturing Base, Sales Area and Its Competitors
Table 104. Merck & Co., Inc. Oral Contraceptive Product Offered
Table 105. Merck & Co., Inc. Oral Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 106. Merck & Co., Inc. Main Business
Table 107. Merck & Co., Inc. Latest Developments
Table 108. Janssen Global Services, LLC Basic Information, Oral Contraceptive Manufacturing Base, Sales Area and Its Competitors
Table 109. Janssen Global Services, LLC Oral Contraceptive Product Offered
Table 110. Janssen Global Services, LLC Oral Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 111. Janssen Global Services, LLC Main Business
Table 112. Janssen Global Services, LLC Latest Developments
Table 113. Mankind Pharma Ltd. Basic Information, Oral Contraceptive Manufacturing Base, Sales Area and Its Competitors
Table 114. Mankind Pharma Ltd. Oral Contraceptive Product Offered
Table 115. Mankind Pharma Ltd. Oral Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 116. Mankind Pharma Ltd. Main Business
Table 117. Mankind Pharma Ltd. Latest Developments
Table 118. Teva Pharmaceutical Industries Ltd Basic Information, Oral Contraceptive Manufacturing Base, Sales Area and Its Competitors
Table 119. Teva Pharmaceutical Industries Ltd Oral Contraceptive Product Offered
Table 120. Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 121. Teva Pharmaceutical Industries Ltd Main Business
Table 122. Teva Pharmaceutical Industries Ltd Latest Developments
Table 123. Allergan, plc (Actavis) Basic Information, Oral Contraceptive Manufacturing Base, Sales Area and Its Competitors
Table 124. Allergan, plc (Actavis) Oral Contraceptive Product Offered
Table 125. Allergan, plc (Actavis) Oral Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 126. Allergan, plc (Actavis) Main Business
Table 127. Allergan, plc (Actavis) Latest Developments
Table 128. Piramal Enterprises Ltd. Basic Information, Oral Contraceptive Manufacturing Base, Sales Area and Its Competitors
Table 129. Piramal Enterprises Ltd. Oral Contraceptive Product Offered
Table 130. Piramal Enterprises Ltd. Oral Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 131. Piramal Enterprises Ltd. Main Business
Table 132. Piramal Enterprises Ltd. Latest Developments
Table 133. Beijing Zizhu Pharm Basic Information, Oral Contraceptive Manufacturing Base, Sales Area and Its Competitors
Table 134. Beijing Zizhu Pharm Oral Contraceptive Product Offered
Table 135. Beijing Zizhu Pharm Oral Contraceptive Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 136. Beijing Zizhu Pharm Main Business
Table 137. Beijing Zizhu Pharm Latest Developments
List of Figures
Figure 1. Picture of Oral Contraceptive
Figure 2. Oral Contraceptive Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Contraceptive Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Oral Contraceptive Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Oral Contraceptive Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Combination
Figure 10. Product Picture of Progestin Only
Figure 11. Product Picture of Others
Figure 12. Global Oral Contraceptive Sales Market Share by Type in 2021
Figure 13. Global Oral Contraceptive Revenue Market Share by Type (2017-2022)
Figure 14. Oral Contraceptive Consumed in Male
Figure 15. Global Oral Contraceptive Market: Male (2017-2022) & (K Units)
Figure 16. Oral Contraceptive Consumed in Female
Figure 17. Global Oral Contraceptive Market: Female (2017-2022) & (K Units)
Figure 18. Global Oral Contraceptive Sales Market Share by Application (2017-2022)
Figure 19. Global Oral Contraceptive Revenue Market Share by Application in 2021
Figure 20. Oral Contraceptive Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Oral Contraceptive Revenue Market Share by Company in 2021
Figure 22. Global Oral Contraceptive Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Oral Contraceptive Revenue Market Share by Geographic Region in 2021
Figure 24. Global Oral Contraceptive Sales Market Share by Region (2017-2022)
Figure 25. Global Oral Contraceptive Revenue Market Share by Country/Region in 2021
Figure 26. Americas Oral Contraceptive Sales 2017-2022 (K Units)
Figure 27. Americas Oral Contraceptive Revenue 2017-2022 ($ Millions)
Figure 28. APAC Oral Contraceptive Sales 2017-2022 (K Units)
Figure 29. APAC Oral Contraceptive Revenue 2017-2022 ($ Millions)
Figure 30. Europe Oral Contraceptive Sales 2017-2022 (K Units)
Figure 31. Europe Oral Contraceptive Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Oral Contraceptive Sales 2017-2022 (K Units)
Figure 33. Middle East & Africa Oral Contraceptive Revenue 2017-2022 ($ Millions)
Figure 34. Americas Oral Contraceptive Sales Market Share by Country in 2021
Figure 35. Americas Oral Contraceptive Revenue Market Share by Country in 2021
Figure 36. United States Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Oral Contraceptive Sales Market Share by Region in 2021
Figure 41. APAC Oral Contraceptive Revenue Market Share by Regions in 2021
Figure 42. China Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Oral Contraceptive Sales Market Share by Country in 2021
Figure 49. Europe Oral Contraceptive Revenue Market Share by Country in 2021
Figure 50. Germany Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Oral Contraceptive Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Oral Contraceptive Revenue Market Share by Country in 2021
Figure 57. Egypt Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Oral Contraceptive Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Oral Contraceptive in 2021
Figure 63. Manufacturing Process Analysis of Oral Contraceptive
Figure 64. Industry Chain Structure of Oral Contraceptive
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119

According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......

Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......

Global Contraceptives Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141

According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period. The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......

Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108

According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period. The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......

Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 99

Market Overview of Global Menopausal Hot Flashes market: According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......

Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 139

Report Overview: This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs. The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......

Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 122

Report Overview: The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......

Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 108

Market Overview of Global Bacterial Vaginosis Drug market: According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years. Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......

Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Tocolysis Drugs market: According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs